Equities
North America
Europe
Asia
Oceania
Middle East
South America
Africa
»
More Equities
Indexes
America
DOW JONES
NASDAQ COMP
S&P 500
NASDAQ 100
TSX COMP
MEXICO IPC
BOVESPA
Index and indicators
VOLATILITY
DOLLAR INDEX
»
More Indexes
Europe
FTSE 100
DAX
CAC 40
BEL 20
ATHEX COMP
RUSLAND RTS
SMI
IBEX 35
MILANO MIB
AEX
PSI 20
POLAND WIG
Asia, Pacific
NIKKEI 225
SHANGHAI COMP
HANG SENG
KOSPI COMP
SENSEX
TAIWAN TWSE
THAILAND 50
SYDNEY ASX
Middle East
EGX 30
TELAVIV 25
Commodities
Energy
Crude Oil (WTI)
Crude Oil (BRENT)
URANIUM
Index and indicators
CRB COMMODITY
BALTIC DRY
»
More Commodities
Metals
GOLD
SILVER
PLATINUM
PALLADIUM
ALUMINIUM
COPPER
LEAD
TIN
ZINC
Agriculture
COFFEE
SUGAR
CORN
COCOA
COTTOM
WHEAT
PALM IOL
SOYBEANS
Currencies
EUR / USD
USD / JPY
GBP / USD
AUD / USD
USD / CHF
USD / CAD
»
More Currencies
News
Latest News
Markets
Commodities
Business Leaders
Most Popular News
Hot News
Finance Calendar
Economic Calendar
Companies
All News
Press Releases
Events
Corporate actions
Economy & Forex
All News
Currencies / Forex
Economic Events
Press releases
Analysis
All Analysis
Commentaries
Stock Trading Strategies
Index Analysis
Forex Analysis
Commodity Analysis
Top & Flop
Gainers & Losers
Unusual Volumes
STIM
Top / Flop RSI
Top / Flop Gaps
Top / Flop Capitalizations
Market Screener
Technical Analysis
Oversold stocks
Overbought stocks
Close to resistances
Close to supports
Accumulation phase
Most volatile stocks
Fundamentals
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Market Screener
Sectors
Finance Calendar
Calendar
Finance Calendar
Economic Calendar
4-Traders Homepage
>
Shares
>
Nasdaq
>
Biota Pharmaceuticals Inc
NABI
US6295191091
BIOTA PHARMACEUTICALS INC
(NABI)
2
End-of-day quote Nasdaq - 11/12
10.8
0.00%
05/10
BIOTA PHARMACEUTICALS INC
: Biota Pharmaceuticals Reports Second Quarter Fi..
2012
NABI BIOPHARMACEUTICALS
: Effects Reverse Stock Split and Announces the Com..
2012
BIOTA PHARMACEUTICALS INC
: ex-dividend day
Summary
Chart Analysis
News
Calendar
Company
Financials
Forum
Sector
Healthcare
Biotechnology / Pharmaceuticals
Biotechnology / Pharmaceuticals
Pharmaceuticals - Generic / Specialty
Surperformance© rating of Biota Pharmaceuticals Inc
Overall rating
In sector
In country
Trading Rating
-
-
-
Investor Rating
-
-
-
Growth (Revenue)
-
-
-
Valuation
-
-
-
Finances
-
-
-
Profitability
Earnings quality
Business Predictability
-
-
-
PER
-
-
-
Potential
-
-
-
Yield
-
-
-
Consensus
-
-
-
7 days EPS revision
-
-
-
4 months EPS revision
-
-
-
1 year EPS revision
-
-
-
4 months Revenue revision
-
-
-
1 year Revenue revision
-
-
-
More Ratings
Sector Pharmaceuticals - Generic / Specialty
Country
Trading Rating
Investor Rating
ABBVIE INC
USA
ASTRAZENECA PLC
United Kingdom
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Japan
ALLERGAN, INC.
USA
MCKESSON CORPORATION
USA
ASTELLAS PHARMA INC
Japan
VALEANT PHARMACEUTICALS INTL INC
Canada
OTSUKA HOLDINGS CO LTD
Japan
SUN PHARMACEUTICAL INDUSTRIES LIMITED
INDIA
ZOETIS INC
USA
EISAI CO., LTD
Japan
AMERISOURCEBERGEN CORP.
USA
GRIFOLS SA
Spain
PERRIGO COMPANY
USA
ASPEN PHARMACARE HOLDINGS LIMITED
South Africa
FOREST LABORATORIES, INC.
USA
MERCK KGAA
Germany
YUNNAN BAIYAO GROUP CO., LTD
CHINA
PT KALBE FARMA TBK
INDONESIA
SHIONOGI & CO LTD
Japan
ONO PHARMACEUTICAL CO., LTD.
Japan
MITSUBISHI TANABE PHARMA CORPORATION
Japan
SINOPHARM HOLDING CO LTD
Hong Kong
KYOWA HAKKO KIRIN CO LTD
Japan
DAINIPPON SUMITOMO PHARMA CO., LTD.
Japan
Sector Pharmaceuticals - Generic / Specialty
Data source :
© 2013 Thomson Reuters
Ratings :
© 2013 Surperformance
Advertisement
Loading...
Dynamic quotes
ON
|
OFF
My Watchlist
|
My Portfolio
Copyright © 2013 Surperformance. All rights reserved.